⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30338733 | 1.00 | — | — | |
| SCHEMBL31286309 | 0.78 | GRM5 (0.59) | — | |
| SCHEMBL15870932 | 0.78 | GRM5 (0.59) | — | |
| SCHEMBL76549 | 0.74 | — | — | |
| SCHEMBL151926 | 0.74 | — | — | |
| SCHEMBL29892542 | 0.74 | — | — | |
| SCHEMBL10572727 | 0.74 | — | — | |
| SCHEMBL2212141 | 0.74 | — | — | |
| SCHEMBL445201 | 0.74 | — | — | |
| SCHEMBL5623067 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122132-A1 | NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2025-04-17 | — | — | US | claimed |
| EP-3990417-B1 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | LINCOLN UNIV (NZ) | 2024-03-27 | — | — | EP | claimed |
| US-20230202941-A1 | NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2023-06-29 | — | — | US | claimed |
| CN-115867525-A | Improvements in and relating to nitrification inhibitors | 林肯大学 | 2023-03-28 | — | — | CN | claimed |
| US-11578013-B2 | Nitrification inhibitors | LINCOLN UNIVERSITY (NZ) | 2023-02-14 | — | — | US | claimed |
| US-20220153655-A1 | NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2022-05-19 | — | — | US | claimed |
| EP-3990417-A1 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | Lincoln University (NZ) | 2022-05-04 | — | — | EP | claimed |
| WO-2021242122-A1 | IMPROVEMENTS IN AND RELATING TO NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2021-12-02 | — | — | WO | claimed |
| EP-2445897-B1 | NOVEL INDAZOLE ARYLAMIDES AS P2X3 AND/OR P2X2/3 ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2014-03-19 | — | — | EP | claimed |
| EP-2176238-B1 | MORPHOLINO PYRIMIDINE DERIVATIVES USED IN DISEASES LINKED TO MTOR KINASE AND/OR PI3K | ASTRAZENECA AB (SE) | 2012-04-18 | — | — | EP | claimed |
| EP-1768978-B1 | 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2008-07-09 | — | — | EP | claimed |
| EP-1347957-B1 | DELTA 1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2005-09-07 | — | — | EP | claimed |
| EP-4582426-A1 | PAN-KRAS INHIBITOR COMPOUND | Adlai Nortye Biopharma Co., Ltd. (CN) | 2025-07-09 | — | — | EP | disclosed |
| US-20250122132-A1 | NITRIFICATION INHIBITORS | LINCOLN UNIVERSITY (NZ) | 2025-04-17 | — | — | US | disclosed |
| US-20240360104-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2024-10-31 | — | — | US | disclosed |
| US-20240270753-A1 | HETEROCYCLIC COMPOUND FOR INHIBITING SHP2 ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2024-08-15 | — | — | US | disclosed |
| WO-1994027439-A1 | INSECTICIDAL PTERIDINES AND 8-DEAZAPTERIDINES | FMC CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
| CN-1085550-A | New quinazoline ditosylate salt as inhibitors of HIV reverse transcriptase | MERCK & CO INC (US) | 1994-04-20 | — | — | CN | disclosed |
| WO-1993022292-A1 | NEW QUINAZOLINES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1993-11-11 | — | — | WO | disclosed |
| EP-0569083-A1 | New quinazolines as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-11-10 | — | — | EP | disclosed |